Compare Mesoblast Limited (MESO) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs SMX Security Matters plc — how do they compare? Mesoblast Limited trades at $16.08 (market cap $2.17B), while SMX Security Matters plc trades at $18.25 (market cap $16.38M). The key difference: Mesoblast Limited is far larger — about 132.5× SMX Security Matters plc's market cap, and Mesoblast Limited is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| MESO | SMX | |
|---|---|---|
Market Cap | $2.17B | $16.38M |
Sector | Technology | Technology |
52-Week High | $20.96 | $295.56K |
52-Week Low | $12.88 | $12.87 |
Enterprise Value | $2.17B | $13.35M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.63, down 3.98% on the day, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth with Ryoncil generating $115 million in annual revenue, though it remains unprofitable with a net loss of $102 million. Recent developments include positive Phase 3 trial progress and FDA BLA filings for new treatments.
Investment outlook balances promising pipeline progress against significant financial losses. The stock offers growth potential through commercial expansion but carries substantial risk from continued cash burn and regulatory hurdles. Analyst consensus leans bullish with 45% buy ratings, reflecting optimism about the company's transition to commercial-stage operations.
SMX trades at $17.66, up 6.9% today, with neutral technical signals and bearish moving averages. The stock shows a P/B of 1.85 but negative profitability metrics, including a -2,216.26% ROE. Recent news highlights balance sheet strengthening and commercialization progress in recycled materials tracking technology, amid regulatory tailwinds for verified plastics.
Outlook hinges on execution of global strategy and policy-driven demand, but high financial losses and reverse stock splits signal substantial risk. Investor sentiment is cautious despite positive media coverage on industry positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
